Add to ORKGA second generation test for HCV antibody detection in sera coming from Stip county is used. The percentage of antibodies positive blood donors in Stip is very similar to to that in the Republic of Macedonia, 1,00% in Stip and 1.15% in Macedonija. Some of the causes related to the possibility that the real percentage of HCV antibodies positive blood donors is higher than that found are presented. The necessity of the introduction of a systemic use of HCV antibodies determination in blood donors is emphasized
Background: Blood transfusion safety is based on reliable donor screening for transmissible infectio...
Hepatitis C is a blood borne liver disease caused by hepatitis C virus (HCV). First identified in 1...
We have analysed anti-HBc and anti-HCV antibodies in serum samples from 799 donors which had their b...
Recently a recombinant polypeptide of hepatitis C virus (HCV) has been developed by the Chiron Corpo...
Abstract. The prevalence of HCV seropositivity observed in various populations raise the issue of th...
The anti-HCV antibody (C100-3) is present in the serum of 70-90% of patients that are carriers of po...
Background and aims. In Europe a wide variation in HCV prevalence between countries was described, r...
Goal: To find the incidence of HBsAg, anti-HCV, anti-HIV, CMV antibodies and Treponema pallidum anti...
Introduction:Hepatitis B and C virus infection represent serious health and social problem i R. Mace...
Introduction: Transfusion transmissive diseases have still been serious transfusion and health-socia...
Background: Hepatitis type C virus (HCV) is one of the important threatened infectious blood born vi...
Objective: The objective of this study is to evaluate the prevalence of anti-hepatitis C virus antib...
A very high prevalence of anti-hepatic C virus (anti-HCV) antibodies (63/73, 86.3%) was noted among ...
Abstract. The aim of this study was to determine the prevalence of HCV infection and the signal/cuto...
This cross sectional study was designed to investigate the frequency and potential risk factors of a...
Background: Blood transfusion safety is based on reliable donor screening for transmissible infectio...
Hepatitis C is a blood borne liver disease caused by hepatitis C virus (HCV). First identified in 1...
We have analysed anti-HBc and anti-HCV antibodies in serum samples from 799 donors which had their b...
Recently a recombinant polypeptide of hepatitis C virus (HCV) has been developed by the Chiron Corpo...
Abstract. The prevalence of HCV seropositivity observed in various populations raise the issue of th...
The anti-HCV antibody (C100-3) is present in the serum of 70-90% of patients that are carriers of po...
Background and aims. In Europe a wide variation in HCV prevalence between countries was described, r...
Goal: To find the incidence of HBsAg, anti-HCV, anti-HIV, CMV antibodies and Treponema pallidum anti...
Introduction:Hepatitis B and C virus infection represent serious health and social problem i R. Mace...
Introduction: Transfusion transmissive diseases have still been serious transfusion and health-socia...
Background: Hepatitis type C virus (HCV) is one of the important threatened infectious blood born vi...
Objective: The objective of this study is to evaluate the prevalence of anti-hepatitis C virus antib...
A very high prevalence of anti-hepatic C virus (anti-HCV) antibodies (63/73, 86.3%) was noted among ...
Abstract. The aim of this study was to determine the prevalence of HCV infection and the signal/cuto...
This cross sectional study was designed to investigate the frequency and potential risk factors of a...
Background: Blood transfusion safety is based on reliable donor screening for transmissible infectio...
Hepatitis C is a blood borne liver disease caused by hepatitis C virus (HCV). First identified in 1...
We have analysed anti-HBc and anti-HCV antibodies in serum samples from 799 donors which had their b...